Loading the section…

AMN: financial statements from SEC — TradeAlmanac

AMN

AMN Healthcare Services Inc: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/12/2025	31/12/2024
Revenue	2.73B	2.98B
Cost of revenue	1.96B	2.06B
Gross profit	774M	919M
Selling, general and administrative	593M	632M
Operating expenses	830M	1.02B
Operating income	−55M	−103M
Income tax	−5M	−26M
Net income	−96M	−147M
Earnings per share	−2.48	−3.85
Earnings per share, diluted	−2.48	−3.85
Weighted average shares	39M	38M
Weighted average shares, diluted	39M	38M

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	561M	34M	53M	42M	56M	11M	111M	126M
Receivables	395M	383M	391M

Cash flow

Metric	31/12/2025	31/12/2024
Operating cash flow	269M	320M
Depreciation and amortisation	157M	174M
Share-based compensation	31M	23M
Capital expenditure	36M	81M
Investing cash flow	4M	−80M
Share buybacks	0	0

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator